FindTrial
Sign In

The study of WEI NASAL JET applied to upper gastrointestinal endoscopy and (or) colonoscopy under anesthesia.

Efficacy and Safety of the WEI Nanal Jet Applied to upper gastrointestinal endoscopy and (or) colonoscopy under anesthesia.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003156
Enrollment
Unknown
Registered
2013-04-02
Start date
2013-03-25
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper gastrointestinal endoscopy and (or) colonoscopy under anesthesia

Interventions

Nasal cannula:Nasal cannula
Control:Control

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients receiving upper gastrointestinal endoscopy and (or) colonoscopy under monitored anesthesia care with intravenous propofol infusion and intravenous bolus injection of fentanyl in the first affiliated hospital of Guangzhou University of TCM.

Exclusion criteria

Exclusion criteria: Patients with coagulopathy and tendency of nose bleeding; Patients with any diagnosed cardiac diseases (e.g. cardiac failure, angina, MI, cardiac arrhythmia. etc.); Patients with any diagnosed pulmonary disease (e.g. asthma, COPD, pulmonary embolism, pulmonary edema etc.); Pregnant patients; Patients with liver failure; Patients with kidney failure; Patients with increased intracranial pressure (ICP); Patients receiving emergent surgery; Patients with full stomach; Patients with multiple trauma; ASA III, IV

Design outcomes

Primary

MeasureTime frame
Lowest SaO2;Times needed to use mask ventilation;Nose bleeding;—

Countries

China

Contacts

Public ContactWuhua Ma
gzmwh@yahoo.com.cn+86 13318860680

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026